Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Equity Ratio (2016 - 2025)

Regenxbio has reported Equity Ratio over the past 12 years, most recently at 0.23 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.23 for Q4 2025, down 59.3% from a year ago — trailing twelve months through Dec 2025 was 0.23 (down 59.3% YoY), and the annual figure for FY2025 was 0.23, down 59.3%.
  • Equity Ratio for Q4 2025 was 0.23 at Regenxbio, down from 0.31 in the prior quarter.
  • Over the last five years, Equity Ratio for RGNX hit a ceiling of 0.69 in Q4 2021 and a floor of 0.23 in Q4 2025.
  • Median Equity Ratio over the past 5 years was 0.6 (2021), compared with a mean of 0.56.
  • Biggest five-year swings in Equity Ratio: grew 28.63% in 2021 and later tumbled 59.3% in 2025.
  • Regenxbio's Equity Ratio stood at 0.69 in 2021, then fell by 9.72% to 0.62 in 2022, then dropped by 12.32% to 0.54 in 2023, then increased by 2.59% to 0.56 in 2024, then tumbled by 59.3% to 0.23 in 2025.
  • The last three reported values for Equity Ratio were 0.23 (Q4 2025), 0.31 (Q3 2025), and 0.37 (Q2 2025) per Business Quant data.